| scholarly article | Q13442814 |
| P6409 | CORE ID | 92578694 |
| P356 | DOI | 10.1182/BLOOD-2015-09-672303 |
| P953 | full work available at URL | http://eprints.whiterose.ac.uk/97051/ |
| P6366 | Microsoft Academic ID | 2317212228 |
| P932 | PMC publication ID | 4859198 |
| P698 | PubMed publication ID | 26951791 |
| P1154 | Scopus EID | 2-s2.0-84994448884 |
| P50 | author | Kerrie Anne Smith | Q57626798 |
| Robert A S Ariëns | Q53843830 | ||
| P2093 | author name string | Muriel C Maurer | |
| Helen Philippou | |||
| Jacob D Bell | |||
| Kelly Njine Mouapi | |||
| P2860 | cites work | Mechanisms of fibrin polymerization and clinical implications | Q26865281 |
| NMRPipe: a multidimensional spectral processing system based on UNIX pipes | Q27860859 | ||
| Transglutaminase-catalyzed crosslinking of the Aalpha and gamma constituent chains in fibrinogen | Q30830074 | ||
| Screening for the preferred substrate sequence of transglutaminase using a phage-displayed peptide library: identification of peptide substrates for TGASE 2 and Factor XIIIA. | Q33240965 | ||
| Characterizing the specificity of activated Factor XIII for glutamine-containing substrate peptides | Q33248830 | ||
| Direct evidence for specific interactions of the fibrinogen alphaC-domains with the central E region and with each other. | Q33290806 | ||
| Factor XIII activity mediates red blood cell retention in venous thrombi | Q33944224 | ||
| α-α Cross-links increase fibrin fiber elasticity and stiffness | Q34120791 | ||
| Influence of a natural and a synthetic inhibitor of factor XIIIa on fibrin clot rheology. | Q34171820 | ||
| Amino acid sequence studies on the .alpha. chain of human fibrinogen. Exact location of crosslinking acceptor sites | Q34229561 | ||
| The structure and function of the alpha C domains of fibrinogen | Q34311818 | ||
| Transglutaminases: crosslinking enzymes with pleiotropic functions | Q35058528 | ||
| Evaluating factor XIII specificity for glutamine-containing substrates using a matrix-assisted laser desorption/ionization time-of-flight mass spectrometry assay. | Q35153828 | ||
| Reactivity of the N-terminal region of fibronectin protein to transglutaminase 2 and factor XIIIA | Q35213282 | ||
| Human Factor XIII from plasma and platelets. Molecular weights, subunit structures, proteolytic activation, and cross-linking of fibrinogen and fibrin. | Q54049996 | ||
| Fibrinogen Otago: a major alpha chain truncation associated with severe hypofibrinogenaemia and recurrent miscarriage | Q61837235 | ||
| Amino acid sequence studies on the alpha chain of human fibrinogen. Isolation and characterization of two linked alpha-chained cyanogen bromide fragments from fully cross-linked fibrin | Q67561901 | ||
| A photometric assay for blood coagulation factor XIII | Q67943898 | ||
| Factor XIIIa-mediated cross-linking of fibronectin in fibroblast cell layers. Cross-linking of cellular and plasma fibronectin and of amino-terminal fibronectin fragments | Q69948798 | ||
| γ-γ Cross-linking sites in human and bovine fibrin | Q70735278 | ||
| Evidence of intramolecular cross-linked A alpha.gamma chain heterodimers in plasma fibrinogen | Q71099271 | ||
| Fibrin--recombinant human factor XIII a-subunit association | Q72905698 | ||
| Analysis of A alpha 251 fibrinogen: the alpha C domain has a role in polymerization, albeit more subtle than anticipated from the analogous proteolytic fragment X | Q77501904 | ||
| Functional analysis of fibrin {gamma}-chain cross-linking by activated factor XIII: determination of a cross-linking pattern that maximizes clot stiffness | Q80160260 | ||
| Visualization of fibrinogen αC regions and their arrangement during fibrin network formation by high-resolution AFM | Q85956392 | ||
| Factor XIII stiffens fibrin clots by causing fiber compaction | Q87628289 | ||
| Identification of VLDLR as a novel endothelial cell receptor for fibrin that modulates fibrin-dependent transendothelial migration of leukocytes | Q35669254 | ||
| A model of fibrin formation based on crystal structures of fibrinogen and fibrin fragments complexed with synthetic peptides | Q35837087 | ||
| On the mechanism of αC polymer formation in fibrin. | Q35932510 | ||
| Fibrinogen matrix deposited on the surface of biomaterials acts as a natural anti-adhesive coating | Q35998306 | ||
| The molecular physiology and pathology of fibrin structure/function | Q36166852 | ||
| Factor XIIIa-dependent retention of red blood cells in clots is mediated by fibrin α-chain crosslinking | Q36169271 | ||
| Fibrinogen and fibrin structure and functions | Q36230901 | ||
| Identification of the polypeptide chains involved in the cross-linking of fibrin | Q36449299 | ||
| The assembly of nonadhesive fibrinogen matrices depends on the αC regions of the fibrinogen molecule. | Q36451951 | ||
| Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor | Q37020020 | ||
| Factor XIII, clot structure, thrombosis. | Q37971200 | ||
| Substrates of Factor XIII-A: roles in thrombosis and wound healing | Q38052936 | ||
| Fibrin(ogen) and thrombotic disease | Q38117741 | ||
| Factor XIIIa-catalyzed cross-linking of recombinant alpha C fragments of human fibrinogen. | Q38357934 | ||
| Identification of respective lysine donor and glutamine acceptor sites involved in factor XIIIa-catalyzed fibrin α chain cross-linking | Q40042347 | ||
| Identification of the alpha chain lysine donor sites involved in factor XIIIa fibrin cross-linking | Q40930403 | ||
| Coagulation factor XIIIa substrates in human plasma: identification and incorporation into the clot | Q41825512 | ||
| Recommendations for nomenclature on fibrinogen and fibrin. | Q41891506 | ||
| The alphaC domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis | Q41938756 | ||
| Transglutaminase catalyses the modification of glutamine side chains in the C-terminal region of bovine beta-lactoglobulin | Q42111128 | ||
| Transglutaminase-mediated oligomerization of the fibrin(ogen) alphaC domains promotes integrin-dependent cell adhesion and signaling. | Q42243895 | ||
| A non-reactive glutamine residue of alpha2-antiplasmin promotes interactions with the factor XIII active site region. | Q43122044 | ||
| Severe hypodysfibrinogenemia in compound heterozygotes of the fibrinogen AalphaIVS4 + 1G>T mutation and an AalphaGln328 truncation (fibrinogen Keokuk). | Q43494105 | ||
| Characterization of crosslinking sites in fibrinogen for plasminogen activator inhibitor 2 (PAI-2). | Q43680324 | ||
| The effect of blood coagulation factor XIII on fibrin clot structure and fibrinolysis. | Q45906428 | ||
| Molecular mechanism of the interaction between activated factor XIII and its glutamine donor peptide substrate | Q46134154 | ||
| NMR-based screening method for transglutaminases: rapid analysis of their substrate specificities and reaction rates | Q46143678 | ||
| Structural features of glutamine substrates for human plasma factor XIIIa (activated blood coagulation factor XIII) | Q46778185 | ||
| Factor XIIIa mediated attachment of S. aureus fibronectin-binding protein A (FnbA) to fibrin: identification of Gln103 as a major cross-linking site | Q46929376 | ||
| The activation peptide cleft exposed by thrombin cleavage of FXIII-A(2) contains a recognition site for the fibrinogen α chain. | Q51755292 | ||
| An engineered fibrinogen variant AαQ328,366P does not polymerise normally, but retains the ability to form α cross-links. | Q51755759 | ||
| Roles of fibrin α- and γ-chain specific cross-linking by FXIIIa in fibrin structure and function. | Q52840471 | ||
| Interactions between factor XIII and the alphaC region of fibrinogen. | Q52846367 | ||
| A novel fibrinogen variant (fibrinogen Seoul II; AalphaGln328Pro) characterized by impaired fibrin alpha-chain cross-linking. | Q53596109 | ||
| P433 | issue | 18 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2241-2248 | |
| P577 | publication date | 2016-03-07 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Ranking reactive glutamines in the fibrinogen αC region that are targeted by blood coagulant factor XIII. | |
| P478 | volume | 127 |
Search more.